High-dose i.v. human immunoglobulin in a case with infantile opsoclonus polymyoclonia syndrome.
We report a 14-month-old male with infantile opsoclonus polymyoclonia syndrome. His clinical disabilities responded favorably to high-dose human immunoglobulin therapy. High dose immunoglobulin therapy is one of the therapies for patients with this syndrome.